QUICK LINKS
MAIN MENU
CONNECT WITH US

Button

Clinical Trial Details

Title
GS-US-445-4189- A Randomized, Phase 2, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of Filgotinib, GS-9876 and GS-4059 in Adult Subjects with Active Sjogren’s Syndrome
Investigators

Principal Investigator
Gurjit S. Kaeley, M.D.
Medicine

Resources

News & Announcements

Upcoming Events

Apr 14